The Efficacy of Repetitive Transcranial Magnetic Stimulation in Patients With Chronic Subjective Tinnitus

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

The aim of this study is to compare the efficacy of frequency-specific patterned repetitive transcranial magnetic stimulation (rTMS) and 1Hz rTMS for the treatment of chronic subjective tinnitus. In this single-blind randomized controlled study, patients will be randomly assigned 1:1 to receive two different types of rTMS stimulation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Adults aged between 18 and 80 years old.

• Experiencing persistant subjective tinnitus for at least 3 months.

• A score of 38 or more on THI.

• 50 dB HL or less on the average pure tone threshold (0.5, 1, 2kHz) of the worse ear.

• Voluntarily participate in the study and sign the informed consent form.

• Have normal mental status and cognitive function, and be able to cooperate with the research process.

Locations
Other Locations
China
Eye & ENT Hospital of Fudan University
RECRUITING
Shanghai
Contact Information
Primary
Shan Sun, PhD
sunshine7896@126.com
+86-021-64377134-2033
Backup
Dongmei Tang, PhD
tang.dongm@163.com
+86-13023299189
Time Frame
Start Date: 2024-05-21
Estimated Completion Date: 2025-12-30
Participants
Target number of participants: 120
Treatments
Experimental: frequency-specific patterned rTMS
Patients will receive a 5-day, once-daily frequency-specific patterned rTMS treatment via a circular coil applied to the auditory cortex. Each session will last 40 minutes and will be stimulated at an intensity of 80% resting motor threshold (RMT).
Active_comparator: 1 Hz rTMS
Patients will receive a 5-day, once-daily 1Hz rTMS treatment via a circular coil applied to the auditory cortex. Each session will last 40 minutes and will be stimulated at an intensity of 80% resting motor threshold (RMT).
Related Therapeutic Areas
Sponsors
Leads: Eye & ENT Hospital of Fudan University

This content was sourced from clinicaltrials.gov